Drains Ablation Post Total Hip Arthroplasty : Search for the Least Painful Technique (TADDA)

February 4, 2026 updated by: University Hospital, Rouen
Comparison of ablation technique of drains

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Rouen, France
        • Rouen University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients admitted to the orthopedic surgery department for surgery for a total hip arthroplasty
  2. Signed inform consent form

Exclusion Criteria:

  1. Drain in non-aspirating mode at the time of medical ablation prescription
  2. Administration of analgesic III in the 12 hours preceding the inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Drain ablation - Non Aspiration mode
Drain ablation will be done in non Aspiration mode
Procedure: drain ablation
drain ablation will be done in Aspiration mode or in non Aspiration mode
Other: Drain ablation - Aspiration mode
Drain ablation will be done in Aspiration mode
Procedure: drain ablation
drain ablation will be done in Aspiration mode or in non Aspiration mode

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate the pain felt by the patients at the time of the removal of the drain, using the pain visual analogue scale
Time Frame: 20 minutes
pain will be measured using a visual analogic scale from 0 (for no pain) to 10 (fo maximum pain)
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of haematoma after ablation
Time Frame: Day 2 post ablation
Presence or absence of haematoma will be visually checked
Day 2 post ablation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Rouen

Investigators

  • Principal Investigator: Mylène BONNAIRE, University Hospital, Rouen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 19, 2018

Primary Completion (Actual)

March 6, 2023

Study Completion (Actual)

March 6, 2023

Study Registration Dates

First Submitted

July 24, 2018

First Submitted That Met QC Criteria

December 27, 2018

First Posted (Actual)

December 28, 2018

Study Record Updates

Last Update Posted (Actual)

February 6, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/0382/HP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Arthroplasty

Clinical Trials on drain ablation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe